Department of Dermatology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz (2023) Leipe J, Schmelz R, Riemekasten G, Thaçi D, Henes J, Schäkel K, Pinter A, et al. Journal article A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer (2023) Zhang L, Fan S, Vera J, Lai X Journal article One Website to Gather them All: Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website-A Mixed-methods Approach (2022) Steeb T, Bruetting J, Reinhardt L, Hoffmann J, Weiler N, Heppt M, Erdmann M, et al. Journal article Guidelines for mouse and human DC functional assays (2022) Clausen BE, Amon L, Backer RA, Berod L, Bopp T, Brand A, Burgdorf S, et al. Journal article Guidelines for DC preparation and flow cytometric analysis of human lymphohematopoietic tissues (2022) Heger L, Dudziak D, Amon L, Hatscher L, Kaszubowski T, Lehmann C Journal article Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry (2022) Hanschmann T, Francuzik W, Doelle-Bierke S, Hofmeier KS, Grabenhenrich L, Rueff F, Renaudin JM, et al. Journal article eImmunonkologie: Development and Launch of a Virtual Education Platform for the Immunotherapy of Cutaneous Neoplasms (2022) Kaufmann M, Steeb T, Wessely A, Meyerolbersleben M, French LEE, Berking C, Heppt M Journal article Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies (2022) Leavenworth JW, Lai X, Miao H, Wang D, Zhao H, Li Y Journal article, Editorial Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML (2022) Fujii SI, Kawamata T, Shimizu K, Nakabayashi J, Yamasaki S, Iyoda T, Shinga J, et al. Journal article Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland (2022) Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akcetin L, et al. Journal article